FDA Issues Warning Letter to Louisiana State University Health Science Center IRB
October 09, 2024
October 09, 2024
WASHINGTON, Oct. 9 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Louisiana State University Health Science Center IRB:
* * *
To: Charles C. Coleman, M.D., IRB Chair, Louisiana State University Health Science Center IRB, 433 Bolivar Street, Suite 206, New Orleans, LA 70112, United States
Dear Dr. Coleman:
This Warning Letter informs you of objectionable conditions observed . . .
* * *
To: Charles C. Coleman, M.D., IRB Chair, Louisiana State University Health Science Center IRB, 433 Bolivar Street, Suite 206, New Orleans, LA 70112, United States
Dear Dr. Coleman:
This Warning Letter informs you of objectionable conditions observed . . .